Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 29.99 Billion CNY | 14.4% |
| 2022 | 26.21 Billion CNY | 2.32% |
| 2021 | 25.62 Billion CNY | 10.19% |
| 2020 | 23.25 Billion CNY | 4.82% |
| 2019 | 22.18 Billion CNY | 23.53% |
| 2018 | 17.95 Billion CNY | 26.13% |
| 2017 | 14.23 Billion CNY | 29.78% |
| 2016 | 10.97 Billion CNY | 33.8% |
| 2015 | 8.19 Billion CNY | 47.16% |
| 2014 | 5.57 Billion CNY | 57.22% |
| 2013 | 3.54 Billion CNY | 38.77% |
| 2012 | 2.55 Billion CNY | 41.78% |
| 2011 | 1.8 Billion CNY | 34.26% |
| 2010 | 1.34 Billion CNY | 18.36% |
| 2009 | 1.13 Billion CNY | 17.44% |
| 2008 | 965.22 Million CNY | 45.61% |
| 2007 | 662.9 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.44 Billion CNY | -9.33% |
| 2024 Q3 | 5.65 Billion CNY | 4.73% |
| 2024 Q2 | 5.39 Billion CNY | -27.5% |
| 2023 Q3 | 6.9 Billion CNY | -14.92% |
| 2023 Q4 | 8.2 Billion CNY | 18.79% |
| 2023 Q1 | 6.75 Billion CNY | 13.76% |
| 2023 FY | 29.99 Billion CNY | 14.4% |
| 2023 Q2 | 8.12 Billion CNY | 20.21% |
| 2022 FY | 26.21 Billion CNY | 2.32% |
| 2022 Q1 | 6.46 Billion CNY | 2.96% |
| 2022 Q4 | 5.93 Billion CNY | -21.59% |
| 2022 Q3 | 7.57 Billion CNY | 21.27% |
| 2022 Q2 | 6.24 Billion CNY | -3.33% |
| 2021 Q3 | 6.78 Billion CNY | 0.56% |
| 2021 FY | 25.62 Billion CNY | 10.19% |
| 2021 Q2 | 6.75 Billion CNY | 16.19% |
| 2021 Q1 | 5.81 Billion CNY | -16.61% |
| 2021 Q4 | 6.27 Billion CNY | -7.58% |
| 2020 Q2 | 5.66 Billion CNY | 39.86% |
| 2020 Q4 | 6.96 Billion CNY | 5.94% |
| 2020 FY | 23.25 Billion CNY | 4.82% |
| 2020 Q1 | 4.04 Billion CNY | -36.56% |
| 2020 Q3 | 6.57 Billion CNY | 16.14% |
| 2019 FY | 22.18 Billion CNY | 23.53% |
| 2019 Q3 | 5.56 Billion CNY | 3.08% |
| 2019 Q1 | 4.83 Billion CNY | 0.89% |
| 2019 Q4 | 6.38 Billion CNY | 14.66% |
| 2019 Q2 | 5.39 Billion CNY | 11.58% |
| 2018 FY | 17.95 Billion CNY | 26.13% |
| 2018 Q3 | 4.64 Billion CNY | -1.86% |
| 2018 Q1 | 3.78 Billion CNY | -5.7% |
| 2018 Q2 | 4.73 Billion CNY | 24.89% |
| 2018 Q4 | 4.79 Billion CNY | 3.29% |
| 2017 Q4 | 4.01 Billion CNY | 9.0% |
| 2017 Q2 | 3.5 Billion CNY | 15.65% |
| 2017 FY | 14.23 Billion CNY | 29.78% |
| 2017 Q1 | 3.03 Billion CNY | -0.59% |
| 2017 Q3 | 3.68 Billion CNY | 5.15% |
| 2016 FY | 10.97 Billion CNY | 33.8% |
| 2016 Q4 | 3.04 Billion CNY | 8.5% |
| 2016 Q1 | 2.42 Billion CNY | 1.11% |
| 2016 Q2 | 2.68 Billion CNY | 10.89% |
| 2016 Q3 | 2.81 Billion CNY | 4.53% |
| 2015 Q3 | 2.11 Billion CNY | 6.78% |
| 2015 Q1 | 1.7 Billion CNY | -2.1% |
| 2015 Q2 | 1.98 Billion CNY | 16.52% |
| 2015 FY | 8.19 Billion CNY | 47.16% |
| 2015 Q4 | 2.39 Billion CNY | 13.23% |
| 2014 Q2 | 1.3 Billion CNY | 19.78% |
| 2014 FY | 5.57 Billion CNY | 57.22% |
| 2014 Q4 | 1.73 Billion CNY | 20.07% |
| 2014 Q3 | 1.44 Billion CNY | 11.32% |
| 2014 Q1 | 1.08 Billion CNY | -4.96% |
| 2013 Q2 | 864.74 Million CNY | 19.54% |
| 2013 Q3 | 813.77 Million CNY | -5.89% |
| 2013 Q1 | 723.39 Million CNY | 0.13% |
| 2013 Q4 | 1.14 Billion CNY | 40.38% |
| 2013 FY | 3.54 Billion CNY | 38.77% |
| 2012 Q4 | 722.44 Million CNY | 17.4% |
| 2012 FY | 2.55 Billion CNY | 41.78% |
| 2012 Q2 | 660.99 Million CNY | 19.04% |
| 2012 Q3 | 615.38 Million CNY | -6.9% |
| 2012 Q1 | 555.25 Million CNY | -1.87% |
| 2011 Q3 | 464.18 Million CNY | 0.15% |
| 2011 Q1 | 307.83 Million CNY | -19.04% |
| 2011 Q2 | 463.49 Million CNY | 50.56% |
| 2011 Q4 | 565.86 Million CNY | 21.9% |
| 2011 FY | 1.8 Billion CNY | 34.26% |
| 2010 Q2 | 342.17 Million CNY | 25.81% |
| 2010 Q4 | 380.22 Million CNY | 9.48% |
| 2010 Q3 | 347.29 Million CNY | 1.5% |
| 2010 FY | 1.34 Billion CNY | 18.36% |
| 2010 Q1 | 271.97 Million CNY | -10.76% |
| 2009 Q3 | 313.94 Million CNY | 0.0% |
| 2009 Q4 | 304.76 Million CNY | -2.92% |
| 2009 FY | 1.13 Billion CNY | 17.44% |
| 2008 FY | 965.22 Million CNY | 45.61% |
| 2007 FY | 662.9 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 17.3 Billion CNY | -73.375% |
| ZJAMP Group Co., Ltd. | 40.94 Billion CNY | 26.733% |
| Luyan Pharma Co.,Ltd. | 19.84 Billion CNY | -51.149% |
| Ji Yao Holding Group Co., Ltd. | 346.1 Million CNY | -8566.765% |